In March 2011 Targeted Genetics Corporation announced the change of the Company’s name to AmpliPhi Biosciences Corporation to reflect its positioning as an innovative biotechnology company focused on the advancement of new generation anti-bacterial therapeutics.
; Targeted Genetics Corporation is a biotechnology Company committed to the development and commercialization of INNOVATIVE-TARGETED molecular therapies for the prevention and treatment of inflammatory arthritis and other acquired and inherited diseases with significant unmet medical need. The Company has capabilities in the development and manufacturing of gene delivery technologies to advance...